Single Cell Analysis – Discover Pharma

Welcome to Discover Pharma! Today is : April 2, 2026

Single Cell Analysis

Artificial Intelligence,Biotech,Chronic diseases,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development,Single Cell analysis,Technology and platforms
Immunai signs $85 million AstraZeneca deal to advance inflammatory bowel disease target
Immunai has signed an agreement worth up to $85 million [...]

October 16, 2025
European biotech,Genomics and sequencing,Medical devices,Partnerships & Funding,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms
Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation
Lithuania’s life sciences sector is preparing to showcase its rapid [...]

September 15, 2025
Genomics and sequencing,Partnerships & Funding,Research & Development,Single Cell analysis,Technology and platforms
10x Genomics to acquire Scale Biosciences to boost single cell analysis capabilities
10x Genomics has agreed to acquire Scale Biosciences, a specialist [...]

August 8, 2025
CDMOs & Manufacturing,Drug Development,Market Access & Commercialization,Partnerships & Funding,Technology and platforms
Sphere Bio enters China market with Redbert Biotechnology distribution deal
Sphere Bio has signed an exclusive distribution agreement with Redbert [...]

June 27, 2025
Cell & Gene Therapy
Sphere Bio expands APAC distribution network to support single-cell analysis demand
April 24, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK